Opinion pieces from oncology specialists in Australia and around the world.
A new Tel Aviv University study addresses the challenges of nanoparticle-based cancer-targeting strategies. It also…
Antolin Bonnett, The Conversation Australia loses nearly A$2 billion of GDP every year due to…
Jane Tiller, Monash University and Paul Lacaze, Monash University You might be intrigued by what…
Fabian V. Filipp, University of California, Merced Because of advances in drug design and precision…
Nicholas Huntington, Walter and Eliza Hall Institute Keytruda (generic name pembrolizumab) is an immunotherapy drug…
A first-of-its-kind drug targeting a fused gene found in many types of cancer was effective…
Marianne J. Cronjé, University of Johannesburg and Reinout Meijboom, University of Johannesburg The development of…
Colorectal cancer is the third most common cancer in men and the second most common…
A Case Western Reserve University School of Medicine researcher has compiled evidence from more than…
About one third of cancer cases are estimated to be linked to dietary and other…